PRESS RELEASE published on 10/08/2025 at 07:00, 11 months 12 days ago Communiqué de presse : AlphaMedixTM (212Pb-DOTAMTATE) a satisfait l’ensemble des critères d’évaluation principaux d’efficacité lors de l’essai de phase 2, démontrant des bénéfices cliniquement significatifs chez les patients atteints AlphaMedixTM (212Pb-DOTAMTATE) satisfait les critères d'évaluation principaux d'efficacité dans l'essai de phase 2 pour les tumeurs neuroendocrines gastro-entéro-pancréatiques. Résultats prometteurs d'alphathérapie ciblée au plomb-212 Essai De Phase 2 Tumeurs Neuroendocrines AlphaMedixTM 212Pb-DOTAMTATE Alphathérapie Ciblée
BRIEF published on 09/24/2025 at 07:10, 11 months 26 days ago Sanofi investit 625 millions de dollars pour booster Sanofi Ventures Investissement Innovation Santé Numérique Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:10, 11 months 26 days ago Sanofi invests $625 million to boost Sanofi Ventures Innovation Digital Health Investment Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:05, 11 months 26 days ago Sanofi Releases Q3 2025 Aide Mémoire Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
PRESS RELEASE published on 09/24/2025 at 07:05, 11 months 26 days ago Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Sanofi investit 625 millions de dollars supplémentaires dans Sanofi Ventures pour accélérer les investissements en biotechnologies et innovation numérique dans la santé Investissement Innovation Santé Numérique Sanofi Biotechnologies
BRIEF published on 09/24/2025 at 07:05, 11 months 26 days ago Sanofi publie son aide-mémoire pour le troisième trimestre 2025 Relations Avec Les Investisseurs Sanofi Annonce Des Résultats Modélisation Financière T3 2025
PRESS RELEASE published on 09/24/2025 at 07:05, 11 months 26 days ago Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines Digital Health Investment Biotech Ventures Sanofi
PRESS RELEASE published on 09/24/2025 at 07:00, 11 months 26 days ago Press release: Availability of the Q3 2025 Aide mémoire Sanofi announces availability of Q3 2025 Aide mémoire for financial modeling purposes. Document covers non-comparable items, foreign currency impact, and share count Investors Sanofi Financial Modeling Aide Mémoire Q3 2025
BRIEF published on 09/23/2025 at 07:05, 11 months 27 days ago La thérapie SAR446268 de Sanofi progresse aux États-Unis Thérapie Génique Sanofi SAR446268 FDA Admission Dystrophie Myotonique
BRIEF published on 09/23/2025 at 07:05, 11 months 27 days ago Sanofi's SAR446268 Therapy Advances in the United States Gene Therapy Sanofi SAR446268 FDA Admission Myotonic Dystrophy
Published on 09/19/2026 at 00:55, 1 day 14 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 1 day 17 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 18 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 15:10, 10 minutes ago MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 6 hours 15 minutes ago Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026
Published on 09/20/2026 at 06:30, 8 hours 50 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 10 hours 45 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 22 hours 40 minutes ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/18/2026 at 18:34, 1 day 20 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 1 day 20 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 17:45, 1 day 21 hours ago Communiqué de presse_Carrefour Bond_Septembre 2026